Free Trial

Avidity Biosciences (RNA) SEC Filings & 10K Form

Avidity Biosciences logo
$26.68 -0.23 (-0.85%)
Closing price 04:00 PM Eastern
Extended Trading
$26.68 0.00 (0.00%)
As of 05:07 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Recent Avidity Biosciences SEC Filings

DateFilerForm TypeView
04/03/2025
3:56 PM
Avidity Biosciences (Issuer)
Gallagher Kathleen P. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/25/2025
7:50 AM
Avidity Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/21/2025
5:38 PM
Avidity Biosciences (Issuer)
MacLean Michael F (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/21/2025
5:40 PM
Avidity Biosciences (Issuer)
Flanagan W. Michael (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/21/2025
5:42 PM
Avidity Biosciences (Issuer)
Boyce Sarah (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/21/2025
5:44 PM
Avidity Biosciences (Issuer)
Hughes Steven George (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/21/2025
5:36 PM
Avidity Biosciences (Issuer)
McCarthy Teresa (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/17/2025
6:02 AM
Avidity Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/12/2025
3:23 PM
Avidity Biosciences (Issuer)
Flanagan W. Michael (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/11/2025
3:35 PM
Avidity Biosciences (Subject)
Flanagan W. Michael (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/04/2025
5:17 PM
Avidity Biosciences (Issuer)
Gallagher Kathleen P. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/27/2025
3:59 PM
Avidity Biosciences (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
02/27/2025
3:13 PM
Avidity Biosciences (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/14/2025
10:24 AM
Avidity Biosciences (Subject)
JANUS HENDERSON GROUP PLC (Filed by)
Form SCHEDULE 13G
02/05/2025
4:01 PM
Avidity Biosciences (Issuer)
Gallagher Kathleen P. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/03/2025
3:34 PM
Avidity Biosciences (Subject)
Gallagher Kathleen P. (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/23/2025
7:12 PM
Avidity Biosciences (Issuer)
Flanagan W. Michael (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/23/2025
7:14 PM
Avidity Biosciences (Issuer)
McCarthy Teresa (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/23/2025
7:15 PM
Avidity Biosciences (Issuer)
MacLean Michael F (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/23/2025
7:17 PM
Avidity Biosciences (Issuer)
LEVIN ARTHUR A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/23/2025
7:06 PM
Avidity Biosciences (Issuer)
Hughes Steven George (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/23/2025
7:08 PM
Avidity Biosciences (Issuer)
Gallagher Kathleen P. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/23/2025
7:10 PM
Avidity Biosciences (Issuer)
Boyce Sarah (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/22/2025
3:25 PM
Avidity Biosciences (Subject)
Gallagher Kathleen P. (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/08/2025
7:35 PM
Avidity Biosciences (Issuer)
Flanagan W. Michael (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/08/2025
7:22 PM
Avidity Biosciences (Issuer)
Hughes Steven George (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/08/2025
7:24 PM
Avidity Biosciences (Issuer)
Boyce Sarah (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/08/2025
7:26 PM
Avidity Biosciences (Issuer)
MacLean Michael F (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/08/2025
7:29 PM
Avidity Biosciences (Issuer)
Moriarty John B (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/08/2025
7:31 PM
Avidity Biosciences (Issuer)
McCarthy Teresa (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/08/2025
7:13 PM
Avidity Biosciences (Issuer)
Calderaro Charles III (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/08/2025
7:14 PM
Avidity Biosciences (Issuer)
Mosbrooker Eric (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/08/2025
7:16 PM
Avidity Biosciences (Issuer)
Gallagher Kathleen P. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/08/2025
5:52 PM
Avidity Biosciences (Issuer)
Gallagher Kathleen P. (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
01/08/2025
6:04 PM
Avidity Biosciences (Issuer)
Mosbrooker Eric (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
01/08/2025
5:42 PM
Avidity Biosciences (Issuer)
Calderaro Charles III (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
01/08/2025
5:46 PM
Avidity Biosciences (Issuer)
Hughes Steven George (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
01/08/2025
8:02 AM
Avidity Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/19/2024
5:15 PM
Avidity Biosciences (Issuer)
McCarthy Teresa (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/19/2024
5:15 PM
Avidity Biosciences (Issuer)
Boyce Sarah (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/19/2024
5:16 PM
Avidity Biosciences (Issuer)
MacLean Michael F (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
Crypto’s crashing…but we’re still profiting (Ad)

Most traders are panicking right now. Bitcoin’s dropping. Altcoins are bleeding. The stock market’s a mess. The news is screaming fear. But while most traders watch their portfolios tank…

my friend Joel and his team at The Crypto Code are doing the opposite.
12/19/2024
5:17 PM
Avidity Biosciences (Issuer)
Flanagan W. Michael (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/18/2024
3:46 PM
Avidity Biosciences (Issuer)
McCarthy Teresa (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/13/2024
5:08 PM
Avidity Biosciences (Issuer)
Flanagan W. Michael (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/11/2024
3:59 PM
Avidity Biosciences (Subject)
Flanagan W. Michael (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/20/2024
5:06 PM
Avidity Biosciences (Issuer)
LEVIN ARTHUR A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/20/2024
5:10 PM
Avidity Biosciences (Issuer)
McCarthy Teresa (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/14/2024
4:46 PM
Avidity Biosciences (Subject)
RA CAPITAL MANAGEMENT, L.P. (Filed by)
Form SC 13G/A
11/14/2024
8:39 AM
Avidity Biosciences (Subject)
Avoro Capital Advisors LLC (Filed by)
Form SC 13G
11/12/2024
6:06 AM
Avidity Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/08/2024
3:50 PM
Avidity Biosciences (Issuer)
MacLean Michael F (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/08/2024
12:56 PM
Avidity Biosciences (Subject)
WELLINGTON MANAGEMENT GROUP LLP (Filed by)
Form SC 13G
11/04/2024
9:22 AM
Avidity Biosciences (Subject)
VANGUARD GROUP INC (Filed by)
Form SC 13G/A
10/30/2024
7:01 AM
Avidity Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/23/2024
3:19 PM
Avidity Biosciences (Issuer)
LEVIN ARTHUR A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/21/2024
3:21 PM
Avidity Biosciences (Subject)
LEVIN ARTHUR A (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
10/17/2024
3:20 PM
Avidity Biosciences (Issuer)
McCarthy Teresa (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/16/2024
12:48 PM
Avidity Biosciences (Subject)
LEVIN ARTHUR A (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
10/09/2024
4:23 PM
Avidity Biosciences (Issuer)
Thompson Tamar (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/03/2024
6:02 AM
Avidity Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/01/2024
3:36 PM
Avidity Biosciences (Subject)
Flanagan W. Michael (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/23/2024
7:59 PM
Avidity Biosciences (Issuer)
MacLean Michael F (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/23/2024
8:01 PM
Avidity Biosciences (Issuer)
Boyce Sarah (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/23/2024
8:03 PM
Avidity Biosciences (Issuer)
Flanagan W. Michael (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/23/2024
8:06 PM
Avidity Biosciences (Issuer)
McCarthy Teresa (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/23/2024
3:27 PM
Avidity Biosciences (Subject)
Flanagan W. Michael (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/20/2024
4:19 PM
Avidity Biosciences (Issuer)
LEVIN ARTHUR A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/13/2024
3:25 PM
Avidity Biosciences (Issuer)
Flanagan W. Michael (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/11/2024
3:18 PM
Avidity Biosciences (Subject)
McCarthy Teresa (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/11/2024
3:18 PM
Avidity Biosciences (Subject)
Flanagan W. Michael (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/10/2024
5:26 PM
Avidity Biosciences (Issuer)
LEVIN ARTHUR A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/23/2024
4:46 PM
Avidity Biosciences (Subject)
RTW INVESTMENTS, LP (Filed by)
Form SC 13D/A
08/21/2024
3:30 PM
Avidity Biosciences (Issuer)
LEVIN ARTHUR A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/15/2024
3:43 PM
Avidity Biosciences (Filer)
Form 424B5
08/15/2024
3:46 PM
Avidity Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/13/2024
3:20 PM
Avidity Biosciences (Filer)
Form 424B5
08/09/2024
4:12 PM
Avidity Biosciences (Filer)
Form 424B5
08/09/2024
3:20 PM
Avidity Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/09/2024
3:23 PM
Avidity Biosciences (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/09/2024
6:02 AM
Avidity Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/07/2024
4:46 PM
Avidity Biosciences (Issuer)
Boyce Sarah (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/05/2024
8:11 AM
Avidity Biosciences (Issuer)
Moriarty John B (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/05/2024
8:06 AM
Avidity Biosciences (Issuer)
Moriarty John B (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
07/23/2024
3:22 PM
Avidity Biosciences (Issuer)
LEVIN ARTHUR A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/20/2024
5:47 PM
Avidity Biosciences (Issuer)
Boyce Sarah (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/20/2024
5:48 PM
Avidity Biosciences (Issuer)
MacLean Michael F (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/20/2024
5:49 PM
Avidity Biosciences (Issuer)
McCarthy Teresa (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/20/2024
5:47 PM
Avidity Biosciences (Issuer)
Flanagan W. Michael (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/14/2024
5:54 PM
Avidity Biosciences (Issuer)
Henig Noreen (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/14/2024
5:56 PM
Avidity Biosciences (Issuer)
Thompson Tamar (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/14/2024
5:58 PM
Avidity Biosciences (Issuer)
Boyce Sarah (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
New “Trump” currency proposed in DC (Ad)

According to one of the most connected men in Washington… A surprising new bill was just introduced in Washington. Its purpose: to put Donald Trump’s face on the $100 note. All to celebrate a new “golden age” for America.

When you see what could happen – I think you’ll be excited.
06/14/2024
6:01 PM
Avidity Biosciences (Issuer)
BOESS CARSTEN (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/14/2024
6:03 PM
Avidity Biosciences (Issuer)
LEVIN ARTHUR A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/14/2024
6:06 PM
Avidity Biosciences (Issuer)
Kim Jean Jinsun (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/14/2024
6:07 PM
Avidity Biosciences (Issuer)
MacLean Michael F (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/14/2024
6:09 PM
Avidity Biosciences (Issuer)
Kaye Edward M. MD (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/14/2024
5:52 PM
Avidity Biosciences (Issuer)
WILSON TROY EDWARD (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/14/2024
4:05 PM
Avidity Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/12/2024
3:19 PM
Avidity Biosciences (Filer)
Form 424B5
06/12/2024
3:22 PM
Avidity Biosciences (Subject)
Boyce Sarah (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
(Data available from 1/1/2016 forward)

Remove Ads

Related Companies and Tools


This page (NASDAQ:RNA) was last updated on 4/15/2025 by MarketBeat.com Staff
From Our Partners